More on LABS
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $25.69 |
|
|||
| Open | $0.51 | ||||
| 52 Wk High | $61.31 | ||||
| 52 Wk Low | $35.58 | ||||
| Day High | $25.69 | ||||
| Day Low | $25.69 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 5,694 | ||||
- MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
- MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
- MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
- MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
- Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
- MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
- MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
- MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
- MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
- Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
Entities mentioned with LABS
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- BMO Capital | View Related Stories »
- Crude Oil | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
